A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

A novel variant of the chimeric BCR-ABL mRNA transcript was detected in a patient with Philadelphia chromosome-negative (Ph-) chronic myelogenous leukemia (CML) by multiplex reverse-transcription polymerase chain reaction (RT-PCR). Sequence analysis of the fusion region of the amplified cDNA fragment showed an in-frame joining of exon e6 of the BCR gene and exon a2 of the ABL gene, giving rise to an e6a2 BCR-ABL transcript. This finding was confirmed by Southern blot analysis using a specific probe corresponding to intron 6 of the BCR gene, whereas conventional Southern blot for rearrangement of the major breakpoint cluster region (M-bcr) was negative. Western blot studies detected a BCR-ABL protein slightly larger than p185 BCR-ABL. Metaphase fluorescence in situ hybridization showed an insertion of ABL material into the BCR region without reciprocal BCR translocation. The findings in this case show that atypical BCR-ABL transcripts are detectable even in Ph- CML patients without M-bcr-rearrangements. Multiplex PCR using primers that allow for amplification of all known BCR-ABL transcripts is an appropriate method to exclude these rare variants.

[1]  D. Delia,et al.  Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. , 1995, Cancer research.

[2]  S. Clifton,et al.  Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. , 1995, Genomics.

[3]  J. Melo,et al.  BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia. , 1995, Blood.

[4]  S. Iwata,et al.  Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2. , 1994, Leukemia.

[5]  H. Gralnick,et al.  The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group , 1994, British journal of haematology.

[6]  A. Deisseroth,et al.  BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. , 1994, Blood.

[7]  C. Sawyers,et al.  Differential complementation of Bcr-Abl point mutants with c-Myc. , 1994, Science.

[8]  H. Döhner,et al.  Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. , 1994, Blood.

[9]  T. Lister,et al.  Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia. , 1993, Leukemia.

[10]  G. Saglio,et al.  New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. , 1990, Blood.

[11]  P. Martiat,et al.  Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement. , 1990, Leukemia.

[12]  A. Hagemeijer,et al.  A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1990, Leukemia.

[13]  G. Torelli,et al.  Philadelphia-positive chronic myeloid leukemia with a chromosome 22 breakpoint outside the breakpoint cluster region. , 1987, Blood.

[14]  A. Hagemeijer,et al.  bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. , 1986, Blood.

[15]  J. Melo,et al.  P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? , 1994, Leukemia.

[16]  J. Melo,et al.  An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. , 1994, Leukemia.